The December 2022 World Health Organization (WHO) position paper updates HPV vaccine guidelines to include a single-dose schedule for girls aged 9–14, offering comparable protection to two-dose regimens. These recommendations support the global strategy to eliminate cervical cancer by prioritizing efficient dosing for primary target groups. Read the full publication at WHO .
Human papillomavirus vaccines: WHO position paper, December 2022
